UA88604C2 - Use of antibody binding to alfa-4-integrin for treatment of demyelinating diseases - Google Patents
Use of antibody binding to alfa-4-integrin for treatment of demyelinating diseasesInfo
- Publication number
- UA88604C2 UA88604C2 UAA200508278A UA2005008278A UA88604C2 UA 88604 C2 UA88604 C2 UA 88604C2 UA A200508278 A UAA200508278 A UA A200508278A UA 2005008278 A UA2005008278 A UA 2005008278A UA 88604 C2 UA88604 C2 UA 88604C2
- Authority
- UA
- Ukraine
- Prior art keywords
- demyelination
- compositions
- alfa
- integrin
- treatment
- Prior art date
Links
Abstract
The application provides for methods and compositions for inhibiting demyelination, promoting remyelination and/or treating paralysis in a subject in need thereof. Preferably, such compositions include immunoglobulins (e.g., antibodies, antibody fragments, and recombinantly produced antibodies or fragments), polypeptides (e.g., soluble forms of the ligand proteins for integrins) and small molecules, which when administered in an effective amount inhibits demyelination and/or promotes remyelination in a patient. The compositions and methods described herein can also utilize other anti-inflammatory agents used to palliate conditions and diseases associated with demyelination.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44217103P | 2003-01-24 | 2003-01-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA88604C2 true UA88604C2 (en) | 2009-11-10 |
Family
ID=37959752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200508278A UA88604C2 (en) | 2003-01-24 | 2004-01-26 | Use of antibody binding to alfa-4-integrin for treatment of demyelinating diseases |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1942161B (en) |
UA (1) | UA88604C2 (en) |
ZA (1) | ZA200505869B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2509573C2 (en) * | 2010-07-27 | 2014-03-20 | Олег Ильич Эпштейн | Drug for treating multiple sclerosis and method of treating multiple sclerosis |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2015004436A (en) * | 2012-10-09 | 2015-06-24 | Biogen Idec Inc | Combination therapies and uses for treatment of demyelinating disorders. |
CN106316982B (en) * | 2015-06-30 | 2020-08-14 | 中国人民解放军军事医学科学院毒物药物研究所 | Thiazine amide derivative and use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6060501A (en) * | 1994-06-02 | 2000-05-09 | Schering Aktiengesellschaft | Combined treatment of multiple sclerosis |
-
2004
- 2004-01-26 ZA ZA200505869A patent/ZA200505869B/en unknown
- 2004-01-26 UA UAA200508278A patent/UA88604C2/en unknown
- 2004-01-26 CN CN2004800080890A patent/CN1942161B/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2509573C2 (en) * | 2010-07-27 | 2014-03-20 | Олег Ильич Эпштейн | Drug for treating multiple sclerosis and method of treating multiple sclerosis |
Also Published As
Publication number | Publication date |
---|---|
ZA200505869B (en) | 2006-11-29 |
CN1942161A (en) | 2007-04-04 |
CN1942161B (en) | 2012-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05007823A (en) | Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents. | |
GEP20084484B (en) | Antibodies to insulin-like growth factor i receptor | |
BRPI0410129A (en) | therapeutic use of anti-cs1 antibodies | |
KR101155294B1 (en) | Antibodies that immunospecifically bind to BLyS | |
ATE330631T1 (en) | ANTIBODIES FRAGMENTS FOR THE LOCAL TREATMENT OF EYE DISEASES | |
IS8432A (en) | Antibodies that bind to leukocyte receptor-4 | |
BR0306444A (en) | Use of anti-tnf (alpha) antibodies and another drug | |
DE69738868D1 (en) | ESTATE, AND ITS USE FOR PREVENTING AND DETECTING CANCER | |
EP1408986A4 (en) | Proteomimetic compounds and methods | |
HK1069316A1 (en) | Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases | |
DE60028970D1 (en) | AT HER2 BINDING PEPTIDE COMPOUNDS | |
RU2008128244A (en) | METHODS FOR IDENTIFICATION OF TUMORS SUSCEPTIBLE TO TREATMENT BY ANTIBODIES AGAINST ERBB2 | |
BR0206289A (en) | Anti-tnf (alpha) antibody administration processes | |
ATE454124T1 (en) | RECOMBINANT ANTI-CD30 ANTIBODIES AND USES THEREOF | |
ATE280783T1 (en) | MONOCLONAL ANTI-CD6 ANTIBODIES FOR THE TREATMENT AND DIAGNOSIS OF PSORIASIS | |
ECSP055849A (en) | ANTIBODY ("11C7") ANTI-NOGO A AND ITS PHARMACEUTICAL USE | |
DE60025008D1 (en) | DETERMINATION OF ADRENOMEDULLIN-BINDING PROTEINS | |
MXPA03011499A (en) | Fce fusion proteins for treatment of allergy and asthma. | |
ATE235551T1 (en) | LIGAND (TIE LIGAND-4) FROM TIE-2 RECEPTOR AND ITS USES | |
UA88604C2 (en) | Use of antibody binding to alfa-4-integrin for treatment of demyelinating diseases | |
WO2001007479A3 (en) | Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases | |
ATE255411T1 (en) | HYALURONIC ACID RECEPTOR BINDING SUBSTANCES AND THEIR USE FOR THE TREATMENT OF TUMORS AND RESTENOSIS | |
BR9910589A (en) | Humanized antibody, process to produce humanized antibody vtm1-1, pharmaceutical composition, and, process to treat a patient suffering or at risk from the toxic effects of a verotoxin, and cell line | |
ATE286914T1 (en) | USE OF ANTI-TSH RECEPTOR BLOCKING ANTIBODIES IN THE THERAPY OF HYPERTHYROSIS AND MONOCLONAL ANTIBODIES FOR SUCH USE | |
WO2005087809B1 (en) | Peptides from vitronectin and their therapeutic exploitation for osteoblast adhesion |